Literature DB >> 33663106

Predictors of severe sepsis-related in-hospital mortality based on a multicenter cohort study: The Focused Outcomes Research in Emergency Care in Acute Respiratory Distress Syndrome, Sepsis, and Trauma study.

Akiyoshi Hagiwara1, Noriko Tanaka2, Yosuke Inaba2, Satoshi Gando3,4, Atsushi Shiraishi5, Daizoh Saitoh6, Yasuhiro Otomo7, Hiroto Ikeda8, Hiroshi Ogura9, Shigeki Kushimoto10, Joji Kotani11, Yuichiro Sakamoto12, Yasukazu Shiino13, Shin-Ichiro Shiraishi14, Kiyotsugu Takuma15, Takehiko Tarui16, Ryosuke Tsuruta17, Taka-Aki Nakada18, Toru Hifumi19, Kazuma Yamakawa20, Naoshi Takeyama21, Norio Yamashita22, Toshikazu Abe23, Masashi Ueyama24, Kohji Okamoto25, Junichi Sasaki26, Tomohiko Masuno27, Toshihiko Mayumi28, Seitaro Fujishima29, Yutaka Umemura30, Satoshi Fujimi31.   

Abstract

ABSTRACT: This study aimed to identify prognostic factors for severe sepsis-related in-hospital mortality using the structural equation model (SEM) analysis with statistical causality. Sepsis data from the Focused Outcomes Research in Emergency Care in Acute Respiratory Distress Syndrome, Sepsis, and Trauma study (FORECAST), a multicenter cohort study, was used. Forty seven observed variables from the database were used to construct 4 latent variables. SEM analysis was performed on these latent variables to analyze the statistical causality among these data. This study evaluated whether the variables had an effect on in-hospital mortality. Overall, 1148 patients were enrolled. The SEM analysis showed that the 72-hour physical condition was the strongest latent variable affecting mortality, followed by physical condition before treatment. Furthermore, the 72-hour physical condition and the physical condition before treatment strongly influenced the Sequential Organ Failure Assessment (SOFA) score with path coefficients of 0.954 and 0.845, respectively. The SOFA score was the strongest variable that affected mortality after the onset of severe sepsis. The score remains the most robust prognostic factor and can facilitate appropriate policy development on care.
Copyright © 2021 the Author(s). Published by Wolters Kluwer Health, Inc.

Entities:  

Mesh:

Year:  2021        PMID: 33663106      PMCID: PMC7909210          DOI: 10.1097/MD.0000000000024844

Source DB:  PubMed          Journal:  Medicine (Baltimore)        ISSN: 0025-7974            Impact factor:   1.817


  27 in total

1.  Outcomes in severe sepsis and patients with septic shock: pathogen species and infection sites are not associated with mortality.

Authors:  Jean-Ralph Zahar; Jean-Francois Timsit; Maïté Garrouste-Orgeas; Adrien Français; Aurélien Vesin; Aurélien Vesim; Adrien Descorps-Declere; Yohann Dubois; Bertrand Souweine; Hakim Haouache; Dany Goldgran-Toledano; Bernard Allaouchiche; Elie Azoulay; Christophe Adrie
Journal:  Crit Care Med       Date:  2011-08       Impact factor: 7.598

2.  Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock.

Authors:  Anand Kumar; Daniel Roberts; Kenneth E Wood; Bruce Light; Joseph E Parrillo; Satendra Sharma; Robert Suppes; Daniel Feinstein; Sergio Zanotti; Leo Taiberg; David Gurka; Aseem Kumar; Mary Cheang
Journal:  Crit Care Med       Date:  2006-06       Impact factor: 7.598

3.  The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine.

Authors:  J L Vincent; R Moreno; J Takala; S Willatts; A De Mendonça; H Bruining; C K Reinhart; P M Suter; L G Thijs
Journal:  Intensive Care Med       Date:  1996-07       Impact factor: 17.440

4.  The epidemiology of sepsis in Colombia: a prospective multicenter cohort study in ten university hospitals.

Authors:  Ferney Rodríguez; Lena Barrera; Gisela De La Rosa; Rodolfo Dennis; Carmelo Dueñas; Marcela Granados; Dario Londoño; Francisco Molina; Guillermo Ortiz; Fabián Jaimes
Journal:  Crit Care Med       Date:  2011-07       Impact factor: 7.598

5.  The relationship between glucose metabolism, metabolic syndrome, and bone-specific alkaline phosphatase: a structural equation modeling approach.

Authors:  Ching-Lung Cheung; Kathryn C B Tan; Karen S L Lam; Bernard M Y Cheung
Journal:  J Clin Endocrinol Metab       Date:  2013-06-24       Impact factor: 5.958

Review 6.  The Impact of Timing of Antibiotics on Outcomes in Severe Sepsis and Septic Shock: A Systematic Review and Meta-Analysis.

Authors:  Sarah A Sterling; W Ryan Miller; Jason Pryor; Michael A Puskarich; Alan E Jones
Journal:  Crit Care Med       Date:  2015-09       Impact factor: 7.598

Review 7.  Immunosuppression in sepsis: a novel understanding of the disorder and a new therapeutic approach.

Authors:  Richard S Hotchkiss; Guillaume Monneret; Didier Payen
Journal:  Lancet Infect Dis       Date:  2013-03       Impact factor: 25.071

8.  Severe anemia in Malawian children.

Authors:  Job C J Calis; Kamija S Phiri; E Brian Faragher; Bernard J Brabin; Imelda Bates; Luis E Cuevas; Rob J de Haan; Ajib I Phiri; Pelani Malange; Mirriam Khoka; Paul J M Hulshof; Lisette van Lieshout; Marcel G H M Beld; Yik Y Teo; Kirk A Rockett; Anna Richardson; Dominic P Kwiatkowski; Malcolm E Molyneux; Michaël Boele van Hensbroek
Journal:  N Engl J Med       Date:  2008-02-28       Impact factor: 91.245

Review 9.  SOFA and mortality endpoints in randomized controlled trials: a systematic review and meta-regression analysis.

Authors:  Harm-Jan de Grooth; Irma L Geenen; Armand R Girbes; Jean-Louis Vincent; Jean-Jacques Parienti; Heleen M Oudemans-van Straaten
Journal:  Crit Care       Date:  2017-02-24       Impact factor: 9.097

10.  Epidemiology and outcome of severe sepsis and septic shock in intensive care units in mainland China.

Authors:  Jianfang Zhou; Chuanyun Qian; Mingyan Zhao; Xiangyou Yu; Yan Kang; Xiaochun Ma; Yuhang Ai; Yuan Xu; Dexin Liu; Youzhong An; Dawei Wu; Renhua Sun; Shusheng Li; Zhenjie Hu; Xiangyuan Cao; Fachun Zhou; Li Jiang; Jiandong Lin; Enqiang Mao; Tiehe Qin; Zhenyang He; Lihua Zhou; Bin Du
Journal:  PLoS One       Date:  2014-09-16       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.